Abstract Cognitive enhancement drugs, often referred to as “nootropics” or “smart drugs,” have emerged as a significant area of interest within neuroscience, pharmacology, and bioethics. Originally developed for the treatment of neurological and psychiatric disorders, these pharmacological agents are increasingly used by healthy individuals seeking to improve cognitive functions such [...]
Abstract The paradigm of pharmacotherapy is undergoing a profound transformation as medicine transitions from population-based treatment models to individualized therapeutic strategies. Precision pharmacotherapy represents an emerging clinical framework that integrates pharmacogenomics, molecular biomarkers, and digital health technologies to optimize drug therapy for individual patients. Variability in drug response remains a [...]
Abstract The pharmaceutical industry is undergoing a paradigm shift driven by the integration of artificial intelligence (AI) into drug discovery and development. Traditional drug discovery processes are costly, time-consuming, and associated with high failure rates, often requiring over a decade of research and billions of dollars in investment to bring [...]